Engagement with officials on Bill S-280, An Act respecting a national framework on sickle cell disease, to discuss measures and initiatives to improve care and treatment of Canadians affected by sickle cell disease and increase public awareness of the disease.
Proposition législative, Projet de loi ou résolution
Santé
Federally-funded Public Drug Plans, with respect to reimbursement for drug products for federal plan beneficiaries.
Politique ou Programme
Budget, Santé
Federal programs and budgetary initiatives related to the Federal-Provincial-Territorial funding arrangements regarding pharmaceuticals.
Politique ou Programme
Santé
Guidelines, policies and programs related to regulatory and reporting functions of the Patented Medicine Prices Review Board
Politique ou Programme, Règlement
Santé, Industrie
Innovation, Science and Economic Development Canada and Innovation Agenda, Science and Technology Strategy, or other Government policy or program initiatives to support research and development activities in Canada.
Politique ou Programme
Santé
Proposals to amend guidelines related to the operationalization of the legislation and regulations governing the Patented Medicine Prices Review Board
Politique ou Programme
Santé
Regulatory amendments and/or guidelines related to the Food and Drugs Act Regulations and Health Canada review processes to implement an orphan drug regulatory framework.
Règlement, Politique ou Programme
Santé
The development of a national pharmacare program, including the Canada Drug Agency, a national formulary and a rare diseases strategy